Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients

Neuroblastoma is an aggressive pediatric tumor accounting for ~15% of cancer-associated mortalities in children. Despite the current intensive therapy, >50% of high-risk patients experience tumor relapse or regrowth caused by the activation of minimal residual disease (MRD). Although several MRD...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncol Lett
Auteurs principaux: Hirase, Satoshi, Saitoh, Atsuro, Hartomo, Tri Budi, Kozaki, Aiko, Yanai, Tomoko, Hasegawa, Daiichiro, Kawasaki, Keiichiro, Kosaka, Yoshiyuki, Matsuo, Masafumi, Yamamoto, Nobuyuki, Mori, Takeshi, Hayakawa, Akira, Iijima, Kazumoto, Nishio, Hisahide, Nishimura, Noriyuki
Format: Artigo
Langue:Inglês
Publié: D.A. Spandidos 2016
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950657/
https://ncbi.nlm.nih.gov/pubmed/27446404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4682
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires